| Document Date: 2013-01-31 09:17:07
Open Document File Size: 1.008,03 KBShare Result on Facebook
Company Hoffmann-La Roche Inc. / Sagent Pharmaceuticals Inc. / / Country United States / / Event Product Recall / FDA Phase / Reorganization / Product Issues / / IndustryTerm natural rubber latex / treatment of patients with serious lung disease / / MedicalCondition Most convulsions / OF SEIZURES / hypoventilation / convulsions / myoclonic jerking / serious lung disease / headache / SEIZURES / severe hepatic dysfunction / serious respiratory depression / cardiac dysrhythmia / seizure / pain / vomiting / serious underlying disease / hypersensitivity / respiratory depression / dizziness / concurrent cyclic antidepressant poisoning / liver disease / hepatic disease / alcoholism / status epilepticus / head injury / / Organization NDC Number Description Strength Fill Volume Concentration Closure Unit of Sale / Flumazenil administration / FDA / / / Position sales representative / / Product phenytoin / PreventIV Measures / sedative-hypnotic drug / FLUMAZENIL / ROMAZICON / / ProgrammingLanguage LATEX / / ProvinceOrState Illinois / / URL www.fda.gov/medwatch / www.SagentPharma.com / /
SocialTag |
CATALOG FLUMAZENIL Easy-to-see features right on the package Labels are DistinctIV